Triton Wealth Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $30K | Sell |
10,884
-1,460
| -12% | -$4.03K | 0.02% | 93 |
|
|
2024
Q3 | $31.3K | Sell |
12,344
-1,069
| -8% | -$2.71K | 0.02% | 88 |
|
|
2024
Q2 | $44.3K | Hold |
13,413
| – | – | 0.03% | 83 |
|
|
2024
Q1 | $50.2K | Sell |
13,413
-13,234
| -50% | -$49.5K | 0.03% | 74 |
|
|
2023
Q4 | $133K | Sell |
26,647
-3,000
| -10% | -$15K | 0.09% | 72 |
|
|
2023
Q3 | $129K | Sell |
29,647
-641
| -2% | -$2.78K | 0.09% | 70 |
|
|
2023
Q2 | $137K | Hold |
30,288
| – | – | 0.08% | 82 |
|
|
2023
Q1 | $175K | Sell |
30,288
-3,454
| -10% | -$20K | 0.11% | 76 |
|
|
2022
Q4 | $99.2K | Sell |
33,742
-300
| -0.9% | -$882 | 0.06% | 78 |
|
|
2022
Q3 | $92K | Sell |
34,042
-3,490
| -9% | -$9.43K | 0.05% | 80 |
|
|
2022
Q2 | $140K | Sell |
37,532
-2,900
| -7% | -$10.8K | 0.1% | 79 |
|
|
2022
Q1 | $236K | Hold |
40,432
| – | – | 0.12% | 80 |
|
|
2021
Q4 | $236K | Sell |
40,432
-4,905
| -11% | -$28.6K | 0.12% | 80 |
|
|
2021
Q3 | $304K | Buy |
45,337
+2,180
| +5% | +$14.6K | 0.14% | 79 |
|
|
2021
Q2 | $373K | Buy |
+43,157
| New | +$373K | 0.21% | 73 |
|